Adaptive Biotechnologies Corporation ; Open. ; High. ; 52wk High. ; Volume. m ; Beta. Adaptive Biotechnologies (ADPT) has a beta rating of This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock. ADPT vs Biotech Stocks ; $, $, +%, Strong Buy ; $, $, +%, Strong Buy. Adaptive Biotechnologies Corporation ; Open. ; High. ; 52wk High. ; Volume. m ; Beta. Previous close. The last closing price. $ ; Day range. The range between the high and low prices over the past day. $ - $ ; Year range. The range.
Adaptive Biotechnologies Corporation is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker ADPT. The last closing price for Adaptive. Adaptive Biotechnologies (ADPT) has a beta rating of This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock. Adaptive Biotechnologies Corp ADPT:NASDAQ ; Open ; Day High ; Day Low ; Prev Close ; 52 Week High Adaptive Biotechnologies Corp ; Feb, Reiterated, Goldman, Neutral, $54 → $21 ; Feb, Reiterated, BTIG Research, Buy, $35 → $ Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular. The share price as of August 22, is / share. Previously, on August 23, , the share price was / share. This represents a decline of %. Real time Adaptive Biotechnologies (ADPT) stock price quote, stock graph, news & analysis. Adaptive Biotechnologies is harnessing the immune system to unleash its power as a natural diagnostic and therapeutic tool to propel a paradigm shift in. 14, (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that. The Adaptive Biotechnologies Corp stock price today is What Is the Stock Symbol for Adaptive Biotechnologies Corp? The stock ticker symbol for Adaptive. Historical daily share price chart and data for Adaptive Biotechnologies since adjusted for splits and dividends. The latest closing stock price for.
Senior VP notifies of intention to sell stock. Aug 24 ; Price target increased by % to US$ Aug 05 ; Second quarter earnings: EPS in line with analyst. Adaptive Biotechnologies prices IPO at $20 a share, above previous range of $18 to $ Adaptive Biotechnologies Corp., a life-sciences research and clinical. The current price of ADPT is USD — it has increased by % in the past 24 hours. Watch Adaptive Biotechnologies Corporation stock price performance more. Adaptive Biotechnologies Corporation is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker ADPT. The last closing price for Adaptive. Adaptive Biotechnologies Corp (ADPT) has a Smart Score of 8 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom. Looking to buy Adaptive Biotechnologies Stock? View today's ADPT stock price, trade commission-free, and discuss ADPT stock updates with the investor. The average price target is $ with a high forecast of $ and a low forecast of $ The average price target represents a % change from the last. View Adaptive Biotechnologies Corp. ADPT stock quote prices, financial information, real-time forecasts, and company news from CNN. Stock analysis for Adaptive Biotechnologies Corp (ADPT:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company.
Price Performance ; 3-Month. +%. on 06/20/ Period Open: %. on 08/16/ + (+%). since 05/29/24 ; Week. +%. on. Discover real-time Adaptive Biotechnologies Corporation Common Stock (ADPT) stock prices, quotes, historical data, news, and Insights for informed trading. A high-level overview of Adaptive Biotechnologies Corporation (ADPT) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals. What is Adaptive Biotechnologies Corp share price today? Adaptive Biotechnologies Corp (ADPT) share price today is $ Can Indians buy Adaptive. 14, (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that.
Is Adaptive Biotechnologies (NASDAQ:ADPT) a buy? Compare the latest price, visualised quantitative ratios, annual reports, historical dividends, pricing and. Consensus Rating. Adaptive Biotechnologies has received a consensus rating of Moderate Buy. The company's average rating score is , and is based on 4 buy. Adaptive Biotechnologies Corp (ADPT) stock price, GURU trades, performance, financial stability, valuations, and filing info from GuruFocus.
150 To 130 Pounds Before And After | Dermatologist For Penis